Open tender · Germany · Contract notice

Abschluss einer nicht-exklusiven Rabattvereinbarung nach § 130a Abs. 8 SGB V zum Wirkstoff Perindopril arginin + Amlodipin + Indapamid, ATC C09BX01 f. d. Z. 01.9.26-31.8.28 (zzgl. V.-Option 1x12 Mon)

DAK-Gesundheit

DAK-Gesundheit in Germany is inviting bids for “Abschluss einer nicht-exklusiven Rabattvereinbarung nach § 130a Abs. 8 SGB V zum Wirkstoff Perindopril arginin + Amlodipin + Indapamid, ATC C09BX01 f”. Bids close on 5 July 2029. To qualify, bidders need at least one similar completed work.

The work

Framework agreement for discount contracts on the active substance Perindopril arginin + Amlodipin + Indapamid (ATC C09BX01) to be concluded via a non-exclusive tender process.

  • Active substance: Perindopril arginin + Amlodipin + Indapamid (ATC C09BX01)
  • Contract duration: 01.09.2026 to 31.08.2028 (plus 1x12 month option)
  • Submission via email to openhouse@dak.de

Key facts

Contract period
01.09.2026 to 31.08.2028 (plus 1x12 month option)
Evaluation
Lowest price (L1) among technically qualified bids

What it takes to qualify

Worth a closer look

  • § 130a Absatz 8 SGB V enables statutory health insurance funds and pharmaceutical companies to conclude framework discount contracts for medicinal products to be borne by the statutory health insurance funds.
  • The procedure is not considered to fall within the scope of cartel procurement law due to a lack of a selection decision and the resulting non-discriminatory access for all pharmaceutical companies.

Experience

  • At least 1 similar work — Pharmaceutical company offering drugs with the active substance Perindopril arginin + Amlodipin + Indapamid (ATC C09BX01)

Certifications and registrations

EMLA (European Medicines Licensing Application)Contractor must be a pharmaceutical company with a valid marketing authorization for the specified active substance.
GST registration (optional)

Policy conditions

No reservation, preference or local-content restriction.

Documents to submit

  1. AngebotsschreibenOffer letter submitted electronically via email.
  2. Anerkennung der vertraglichen Maßgaben der DAK-GesundheitSigned contract with name or company stamp submitted via email.
  3. Anlagen 1 und 2 zum VertragFilled-out contract annexes, with Annex 2 as an Excel file, submitted via email.